{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:40:59Z","timestamp":1787002859595,"version":"build-2736575974"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T00:00:00Z","timestamp":1598572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T00:00:00Z","timestamp":1598572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The general anesthetic ketamine has been repurposed by physicians as an anti-depressant and by the public as a recreational drug. However, ketamine use can cause extensive pathological changes, including ketamine cystitis. The mechanisms of ketamine\u2019s anti-depressant and adverse effects remain poorly understood. Here we present evidence that ketamine is an effective L-type Ca\n                    <jats:sup>2+<\/jats:sup>\n                    channel (Cav1.2) antagonist that directly inhibits calcium influx and smooth muscle contractility, leading to voiding dysfunction. Ketamine prevents Cav1.2-mediated induction of immediate early genes and transcription factors, and inactivation of\n                    <jats:italic>Cav1.2<\/jats:italic>\n                    in smooth muscle mimics the ketamine cystitis phenotype. Our results demonstrate that ketamine inhibition of Cav1.2 signaling is an important pathway mediating ketamine cystitis. In contrast, Cav1.2 agonist Bay k8644 abrogates ketamine-induced smooth muscle dysfunction. Indeed, Cav1.2 activation by Bay k8644 decreases voiding frequency while increasing void volume, indicating Cav1.2 agonists might be effective drugs for treatment of bladder dysfunction.\n                  <\/jats:p>","DOI":"10.1038\/s41467-020-18167-4","type":"journal-article","created":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T06:09:48Z","timestamp":1598594988000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Disruption of Cav1.2-mediated signaling is a pathway for ketamine-induced pathology"],"prefix":"10.1038","volume":"11","author":[{"given":"Huan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Vandorpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6228-2512","authenticated-orcid":false,"given":"Seth L.","family":"Alper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark L.","family":"Zeidel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,28]]},"reference":[{"key":"18167_CR1","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1038\/s41380-019-0400-x","volume":"24","author":"RS Duman","year":"2019","unstructured":"Duman, R. S., Shinohara, R., Fogaca, M. V. & Hare, B. Neurobiology of rapid-acting antidepressants: convergent effects on GluA1-synaptic function. Mol. Psychiatry 24, 1816\u20131832 (2019).","journal-title":"Mol. Psychiatry"},{"key":"18167_CR2","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/aps.2016.5","volume":"37","author":"MR Gao","year":"2016","unstructured":"Gao, M. R. & Liu, H. Ketamine use in current clinical practice. Acta Pharmacol. Sin. 37, 865\u2013872 (2016).","journal-title":"Acta Pharmacol. Sin."},{"key":"18167_CR3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature25509","volume":"554","author":"Y Yang","year":"2018","unstructured":"Yang, Y. et al. Ketamine blocks bursting in the lateral habenula to rapidly relieve depression. Nature 554, 317\u2013322 (2018).","journal-title":"Nature"},{"key":"18167_CR4","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature17998","volume":"533","author":"P Zanos","year":"2016","unstructured":"Zanos, P. et al. NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature 533, 481\u2013486 (2016).","journal-title":"Nature"},{"key":"18167_CR5","doi-asserted-by":"crossref","first-page":"7107","DOI":"10.3402\/ehtj.v4i0.7107","volume":"4","author":"SS Kalsi","year":"2011","unstructured":"Kalsi, S. S., Wood, D. M. & Dargan, P. I. The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use. Emerg. Health Threats J. 4, 7107 (2011).","journal-title":"Emerg. Health Threats J."},{"key":"18167_CR6","doi-asserted-by":"crossref","first-page":"e1053","DOI":"10.1542\/peds.2011-0351","volume":"128","author":"RP Flick","year":"2011","unstructured":"Flick, R. P. et al. Cognitive and behavioral outcomes after early exposure to anesthesia and surgery. Pediatrics 128, e1053\u2013e1061 (2011).","journal-title":"Pediatrics"},{"key":"18167_CR7","first-page":"223","volume":"27","author":"JM Pappachan","year":"2014","unstructured":"Pappachan, J. M., Raj, B., Thomas, S. & Hanna, F. W. Multiorgan dysfunction related to chronic ketamine abuse. Bayl. Univ. Med. Cent. 27, 223\u2013225 (2014).","journal-title":"Bayl. Univ. Med. Cent."},{"key":"18167_CR8","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s13181-012-0229-z","volume":"8","author":"C Yiu-Cheung","year":"2012","unstructured":"Yiu-Cheung, C. Acute and chronic toxicity pattern in ketamine abusers in Hong Kong. J. Med. Toxicol. 8, 267\u2013270 (2012).","journal-title":"J. Med. Toxicol."},{"key":"18167_CR9","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/bju.12675","volume":"114","author":"YH Tam","year":"2014","unstructured":"Tam, Y. H. et al. One-stop clinic for ketamine-associated uropathy: report on service delivery model, patients\u2019 characteristics and non-invasive investigations at baseline by a cross-sectional study in a prospective cohort of 318 teenagers and young adults. BJU Int. 114, 754\u2013760 (2014).","journal-title":"BJU Int."},{"key":"18167_CR10","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1111\/j.1464-410X.2012.11028.x","volume":"110","author":"AR Winstock","year":"2012","unstructured":"Winstock, A. R., Mitcheson, L., Gillatt, D. A. & Cottrell, A. M. The prevalence and natural history of urinary symptoms among recreational ketamine users. BJU Int. 110, 1762\u20131766 (2012).","journal-title":"BJU Int."},{"key":"18167_CR11","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.urology.2007.01.038","volume":"69","author":"R Shahani","year":"2007","unstructured":"Shahani, R., Streutker, C., Dickson, B. & Stewart, R. J. Ketamine-associated ulcerative cystitis: a new clinical entity. Urology 69, 810\u2013812 (2007).","journal-title":"Urology"},{"key":"18167_CR12","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1016\/j.ajpath.2015.04.020","volume":"185","author":"YS Juan","year":"2015","unstructured":"Juan, Y. S. et al. Translocation of NF-kappaB and expression of cyclooxygenase-2 are enhanced by ketamine-induced ulcerative cystitis in rat bladder. Am. J. Pathol. 185, 2269\u20132285 (2015).","journal-title":"Am. J. Pathol."},{"key":"18167_CR13","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/bju.12256","volume":"112","author":"CL Lee","year":"2013","unstructured":"Lee, C. L., Jiang, Y. H. & Kuo, H. C. Increased apoptosis and suburothelial inflammation in patients with ketamine-related cystitis: a comparison with non-ulcerative interstitial cystitis and controls. BJU Int. 112, 1156\u20131162 (2013).","journal-title":"BJU Int."},{"key":"18167_CR14","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.3892\/mmr.2014.3110","volume":"11","author":"HC Lin","year":"2015","unstructured":"Lin, H. C. et al. Histopathological assessment of inflammation and expression of inflammatory markers in patients with ketamine-induced cystitis. Mol. Med. Rep. 11, 2421\u20132428 (2015).","journal-title":"Mol. Med. Rep."},{"key":"18167_CR15","doi-asserted-by":"crossref","first-page":"F318","DOI":"10.1152\/ajprenal.00607.2014","volume":"309","author":"KM Liu","year":"2015","unstructured":"Liu, K. M. et al. Ketamine-induced ulcerative cystitis and bladder apoptosis involve oxidative stress mediated by mitochondria and the endoplasmic reticulum. Am. J. Physiol. Ren. Physiol. 309, F318\u2013F331 (2015).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"18167_CR16","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3892\/mmr.2014.2823","volume":"11","author":"CH Shen","year":"2015","unstructured":"Shen, C. H. et al. Biological effect of ketamine in urothelial cell lines and global gene expression analysis in the bladders of ketamineinjected mice. Mol. Med. Rep. 11, 887\u2013895 (2015).","journal-title":"Mol. Med. Rep."},{"key":"18167_CR17","doi-asserted-by":"crossref","first-page":"7313","DOI":"10.1007\/s11033-014-3616-5","volume":"41","author":"D Gu","year":"2014","unstructured":"Gu, D. et al. Long-term ketamine abuse induces cystitis in rats by impairing the bladder epithelial barrier. Mol. Biol. Rep. 41, 7313\u20137322 (2014).","journal-title":"Mol. Biol. Rep."},{"key":"18167_CR18","doi-asserted-by":"crossref","first-page":"F885","DOI":"10.1152\/ajprenal.00483.2015","volume":"310","author":"R Rajandram","year":"2016","unstructured":"Rajandram, R. et al. Intact urothelial barrier function in a mouse model of ketamine-induced voiding dysfunction. Am. J. Physiol. Ren. Physiol. 310, F885\u2013F894 (2016).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"18167_CR19","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/jemt.21014","volume":"74","author":"S Tan","year":"2011","unstructured":"Tan, S. et al. Ketamine effects on the urogenital system\u2013changes in the urinary bladder and sperm motility. Microsc. Res. Tech. 74, 1192\u20131198 (2011).","journal-title":"Microsc. Res. Tech."},{"key":"18167_CR20","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/jat\/29.5.376","volume":"29","author":"P Adamowicz","year":"2005","unstructured":"Adamowicz, P. & Kala, M. Urinary excretion rates of ketamine and norketamine following therapeutic ketamine administration: method and detection window considerations. J. Anal. Toxicol. 29, 376\u2013382 (2005).","journal-title":"J. Anal. Toxicol."},{"key":"18167_CR21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.forsciint.2006.09.001","volume":"170","author":"WC Cheng","year":"2007","unstructured":"Cheng, W. C., Ng, K. M., Chan, K. K., Mok, V. K. & Cheung, B. K. Roadside detection of impairment under the influence of ketamine\u2013evaluation of ketamine impairment symptoms with reference to its concentration in oral fluid and urine. Forensic Sci. Int. 170, 51\u201358 (2007).","journal-title":"Forensic Sci. Int."},{"key":"18167_CR22","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/jat\/25.7.583","volume":"25","author":"KA Moore","year":"2001","unstructured":"Moore, K. A., Sklerov, J., Levine, B. & Jacobs, A. J. Urine concentrations of ketamine and norketamine following illegal consumption. J. Anal. Toxicol. 25, 583\u2013588 (2001).","journal-title":"J. Anal. Toxicol."},{"key":"18167_CR23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1757-5672.2011.00101.x","volume":"4","author":"T Chang","year":"2012","unstructured":"Chang, T., Lin, C. C., Lin, A. T., Fan, Y. H. & Chen, K. K. Ketamine-induced uropathy: a new clinical entity causing lower urinary tract symptoms. Low. Urin. Trac. Symptoms 4, 19\u201324 (2012).","journal-title":"Low. Urin. Trac. Symptoms"},{"key":"18167_CR24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1213\/00000539-198202000-00004","volume":"61","author":"EF Domino","year":"1982","unstructured":"Domino, E. F. et al. Plasma levels of ketamine and two of its metabolites in surgical patients using a gas chromatographic mass fragmentographic assay. Anesth. Analg. 61, 87\u201392 (1982).","journal-title":"Anesth. Analg."},{"key":"18167_CR25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/bja\/77.2.203","volume":"77","author":"JM Malinovsky","year":"1996","unstructured":"Malinovsky, J. M., Servin, F., Cozian, A., Lepage, J. Y. & Pinaud, M. Ketamine and norketamine plasma concentrations after i.v., nasal and rectal administration in children. Br. J. Anaesth. 77, 203\u2013207 (1996).","journal-title":"Br. J. Anaesth."},{"key":"18167_CR26","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jpsychires.2014.12.012","volume":"61","author":"K Xu","year":"2015","unstructured":"Xu, K. et al. Preliminary analysis of positive and negative syndrome scale in ketamine-associated psychosis in comparison with schizophrenia. J. Psychiatr. Res. 61, 64\u201372 (2015).","journal-title":"J. Psychiatr. Res."},{"key":"18167_CR27","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/j.1939-4640.2000.tb02122.x","volume":"21","author":"NF Gonzalez-Cadavid","year":"2000","unstructured":"Gonzalez-Cadavid, N. F., Ryndin, I., Vernet, D., Magee, T. R. & Rajfer, J. Presence of NMDA receptor subunits in the male lower urogenital tract. J. Androl. 21, 566\u2013578 (2000).","journal-title":"J. Androl."},{"key":"18167_CR28","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1096\/fj.09-149856","volume":"24","author":"M Huster","year":"2010","unstructured":"Huster, M., Frei, E., Hofmann, F. & Wegener, J. W. A complex of Ca(V)1.2\/PKC is involved in muscarinic signaling in smooth muscle. FASEB J. 24, 2651\u20132659 (2010).","journal-title":"FASEB J."},{"key":"18167_CR29","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1096\/fj.04-1516fje","volume":"18","author":"JW Wegener","year":"2004","unstructured":"Wegener, J. W. et al. An essential role of Cav1.2 L-type calcium channel for urinary bladder function. FASEB J. 18, 1159\u20131161 (2004).","journal-title":"FASEB J."},{"key":"18167_CR30","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.4014\/jmb.1501.01066","volume":"25","author":"HJ Park","year":"2015","unstructured":"Park, H. J., Min, S. H., Won, Y. J. & Lee, J. H. Asn-linked glycosylation contributes to surface expression and voltage-dependent gating of Cav1.2 Ca(2)(+) channel. J. Microbiol. Biotechnol. 25, 1371\u20131379 (2015).","journal-title":"J. Microbiol. Biotechnol."},{"key":"18167_CR31","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1152\/physrev.00016.2013","volume":"94","author":"F Hofmann","year":"2014","unstructured":"Hofmann, F., Flockerzi, V., Kahl, S. & Wegener, J. W. L-type CaV1.2 calcium channels: from in vitro findings to in vivo function. Physiol. Rev. 94, 303\u2013326 (2014).","journal-title":"Physiol. Rev."},{"key":"18167_CR32","first-page":"1","volume":"125","author":"Activation of Immediate Early Genes by Drugs of Abuse.","year":"1993","unstructured":"Activation of Immediate Early Genes by Drugs of Abuse. Technical review. NIDA Res Monogr. 125, 1\u2013211 (1993).","journal-title":"NIDA Res Monogr."},{"key":"18167_CR33","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/322552a0","volume":"322","author":"JI Morgan","year":"1986","unstructured":"Morgan, J. I. & Curran, T. Role of ion flux in the control of c-fos expression. Nature 322, 552\u2013555 (1986).","journal-title":"Nature"},{"key":"18167_CR34","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/0896-6273(91)90375-A","volume":"7","author":"TH Murphy","year":"1991","unstructured":"Murphy, T. H., Worley, P. F. & Baraban, J. M. L-type voltage-sensitive calcium channels mediate synaptic activation of immediate early genes. Neuron 7, 625\u2013635 (1991).","journal-title":"Neuron"},{"key":"18167_CR35","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0896-6273(90)90115-V","volume":"4","author":"M Sheng","year":"1990","unstructured":"Sheng, M., McFadden, G. & Greenberg, M. E. Membrane depolarization and calcium induce c-fos transcription via phosphorylation of transcription factor CREB. Neuron 4, 571\u2013582 (1990).","journal-title":"Neuron"},{"key":"18167_CR36","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0896-6273(90)90106-P","volume":"4","author":"M Sheng","year":"1990","unstructured":"Sheng, M. & Greenberg, M. E. The regulation and function of c-fos and other immediate early genes in the nervous system. Neuron 4, 477\u2013485 (1990).","journal-title":"Neuron"},{"key":"18167_CR37","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1016\/j.ajpath.2011.08.034","volume":"179","author":"A Ramachandran","year":"2011","unstructured":"Ramachandran, A. et al. FosB regulates stretch-induced expression of extracellular matrix proteins in smooth muscle. Am. J. Pathol. 179, 2977\u20132989 (2011).","journal-title":"Am. J. Pathol."},{"key":"18167_CR38","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1600-0773.1978.tb02244.x","volume":"43","author":"A Forman","year":"1978","unstructured":"Forman, A., Andersson, K. E., Henriksson, L., Rud, T. & Ulmsten, U. Effects of nifedipine on the smooth muscle of the human urinary tract in vitro and in vivo. Acta Pharm. Toxicol. 43, 111\u2013118 (1978).","journal-title":"Acta Pharm. Toxicol."},{"key":"18167_CR39","first-page":"223","volume":"19","author":"JD Hughes","year":"2011","unstructured":"Hughes, J. D., Coles, M. A. & Joyce, A. Calcium channel blocker associated lower urinary tract symptoms in males: an Australian retrospective observational study. Qual. Prim. Care 19, 223\u2013231 (2011).","journal-title":"Qual. Prim. Care"},{"key":"18167_CR40","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0022-5347(17)40635-5","volume":"141","author":"A Mattiasson","year":"1989","unstructured":"Mattiasson, A., Ekstrom, B. & Andersson, K. E. Effects of intravesical instillation of verapamil in patients with detrusor hyperactivity. J. Urol. 141, 174\u2013177 (1989).","journal-title":"J. Urol."},{"key":"18167_CR41","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0022-5347(01)69090-6","volume":"167","author":"G Naglie","year":"2002","unstructured":"Naglie, G. et al. A randomized, double-blind, placebo controlled crossover trial of nimodipine in older persons with detrusor instability and urge incontinence. J. Urol. 167, 586\u2013590 (2002).","journal-title":"J. Urol."},{"key":"18167_CR42","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s005400170017","volume":"15","author":"N Hatakeyama","year":"2001","unstructured":"Hatakeyama, N., Yamazaki, M., Shibuya, N., Yamamura, S. & Momose, Y. Effects of ketamine on voltage-dependent calcium currents and membrane potentials in single bullfrog atrial cells. J. Anesth. 15, 149\u2013153 (2001).","journal-title":"J. Anesth."},{"key":"18167_CR43","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1292\/jvms.60.479","volume":"60","author":"Y Hara","year":"1998","unstructured":"Hara, Y., Chugun, A., Nakaya, H. & Kondo, H. Tonic block of the sodium and calcium currents by ketamine in isolated guinea pig ventricular myocytes. J. Vet. Med. Sci. 60, 479\u2013483 (1998).","journal-title":"J. Vet. Med. Sci."},{"key":"18167_CR44","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1097\/00000542-199512000-00018","volume":"83","author":"M Yamakage","year":"1995","unstructured":"Yamakage, M., Hirshman, C. A. & Croxton, T. L. Inhibitory effects of thiopental, ketamine, and propofol on voltage-dependent Ca2+ channels in porcine tracheal smooth muscle cells. Anesthesiology 83, 1274\u20131282 (1995).","journal-title":"Anesthesiology"},{"key":"18167_CR45","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000138994","volume":"45","author":"M Yamazaki","year":"1992","unstructured":"Yamazaki, M., Ito, Y., Kuze, S., Shibuya, N. & Momose, Y. Effects of ketamine on voltage-dependent Ca2+ currents in single smooth muscle cells from rabbit portal vein. Pharmacology 45, 162\u2013169 (1992).","journal-title":"Pharmacology"},{"key":"18167_CR46","first-page":"PL359","volume":"53","author":"BS Wong","year":"1993","unstructured":"Wong, B. S. & Martin, C. D. Ketamine inhibition of cytoplasmic calcium signalling in rat pheochromocytoma (PC-12) cells. Life Sci. 53, PL359\u2013PL364 (1993).","journal-title":"Life Sci."},{"key":"18167_CR47","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0140-6736(88)92825-5","volume":"2","author":"G Mignot","year":"1988","unstructured":"Mignot, G., Bernard, G. & Chichmanian, R. M. Nifedipine and nocturia. Lancet 2, 857 (1988).","journal-title":"Lancet"},{"key":"18167_CR48","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S0140-6736(86)91127-X","volume":"1","author":"G Williams","year":"1986","unstructured":"Williams, G. & Donaldson, R. M. Nifedipine and nocturia. Lancet 1, 738 (1986).","journal-title":"Lancet"},{"key":"18167_CR49","doi-asserted-by":"crossref","first-page":"e66708","DOI":"10.1371\/journal.pone.0066708","volume":"8","author":"ES Elhebir","year":"2013","unstructured":"Elhebir, E. S., Hughes, J. D. & Hilmi, S. C. Calcium antagonists use and its association with lower urinary tract symptoms: a cross-sectional study. PLoS ONE 8, e66708 (2013).","journal-title":"PLoS ONE"},{"key":"18167_CR50","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1111\/j.1464-410X.2011.10593.x","volume":"109","author":"SA Hall","year":"2012","unstructured":"Hall, S. A. et al. Commonly used antihypertensives and lower urinary tract symptoms: results from the Boston Area Community Health (BACH) Survey. BJU Int. 109, 1676\u20131684 (2012).","journal-title":"BJU Int."},{"key":"18167_CR51","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/nau.22267","volume":"32","author":"H Ito","year":"2013","unstructured":"Ito, H., Taga, M., Tsuchiyama, K., Akino, H. & Yokoyama, O. IPSS is lower in hypertensive patients treated with angiotensin-II receptor blocker: posthoc analyses of a lower urinary tract symptoms population. Neurourol. Urodyn. 32, 70\u201374 (2013).","journal-title":"Neurourol. Urodyn."},{"key":"18167_CR52","doi-asserted-by":"crossref","unstructured":"Hu, Z., Liang, M. C. & Soong, T. W. Alternative splicing of L-type CaV1.2 calcium channels: implications in cardiovascular diseases. Genes 8, 344 (2017).","DOI":"10.3390\/genes8120344"},{"key":"18167_CR53","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1038\/npp.2016.271","volume":"42","author":"ZD Kabir","year":"2017","unstructured":"Kabir, Z. D. et al. Cacna1c in the prefrontal cortex regulates depression-related behaviors via REDD1. Neuropsychopharmacology 42, 2032\u20132042 (2017).","journal-title":"Neuropsychopharmacology"},{"key":"18167_CR54","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.biopsych.2010.06.019","volume":"68","author":"DT Dao","year":"2010","unstructured":"Dao, D. T. et al. Mood disorder susceptibility gene CACNA1C modifies mood-related behaviors in mice and interacts with sex to influence behavior in mice and diagnosis in humans. Biol. Psychiatry 68, 801\u2013810 (2010).","journal-title":"Biol. Psychiatry"},{"key":"18167_CR55","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/mp.2013.107","volume":"19","author":"ES Gershon","year":"2014","unstructured":"Gershon, E. S. et al. A rare mutation of CACNA1C in a patient with bipolar disorder, and decreased gene expression associated with a bipolar-associated common SNP of CACNA1C in brain. Mol. Psychiatry 19, 890\u2013894 (2014).","journal-title":"Mol. Psychiatry"},{"key":"18167_CR56","doi-asserted-by":"crossref","first-page":"8089","DOI":"10.1073\/pnas.0502506102","volume":"102","author":"I Splawski","year":"2005","unstructured":"Splawski, I. et al. Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. Proc. Natl Acad. Sci. USA 102, 8089\u20138096 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"18167_CR57","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0014-2999(87)90480-8","volume":"138","author":"E Mogilnicka","year":"1987","unstructured":"Mogilnicka, E., Czyrak, A. & Maj, J. Dihydropyridine calcium channel antagonists reduce immobility in the mouse behavioral despair test; antidepressants facilitate nifedipine action. Eur. J. Pharm. 138, 413\u2013416 (1987).","journal-title":"Eur. J. Pharm."},{"key":"18167_CR58","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/00008877-199711000-00019","volume":"8","author":"C Cohen","year":"1997","unstructured":"Cohen, C., Perrault, G. & Sanger, D. J. Assessment of the antidepressant-like effects of L-type voltage-dependent channel modulators. Behav. Pharm. 8, 629\u2013638 (1997).","journal-title":"Behav. Pharm."},{"key":"18167_CR59","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/mp.2016.86","volume":"21","author":"A Cipriani","year":"2016","unstructured":"Cipriani, A. et al. A systematic review of calcium channel antagonists in bipolar disorder and some considerations for their future development. Mol. Psychiatry 21, 1324\u20131332 (2016).","journal-title":"Mol. Psychiatry"},{"key":"18167_CR60","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0014-2999(88)90813-8","volume":"151","author":"E Mogilnicka","year":"1988","unstructured":"Mogilnicka, E., Czyrak, A. & Maj, J. BAY K 8644 enhances immobility in the mouse behavioral despair test, an effect blocked by nifedipine. Eur. J. Pharm. 151, 307\u2013311 (1988).","journal-title":"Eur. J. Pharm."},{"key":"18167_CR61","doi-asserted-by":"crossref","first-page":"15228","DOI":"10.1073\/pnas.96.26.15228","volume":"96","author":"HA Jinnah","year":"1999","unstructured":"Jinnah, H. A. et al. Calcium channel activation and self-biting in mice. Proc. Natl Acad. Sci. USA 96, 15228\u201315232 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"18167_CR62","doi-asserted-by":"crossref","first-page":"F1274","DOI":"10.1152\/ajprenal.00318.2017","volume":"313","author":"H Chen","year":"2017","unstructured":"Chen, H., Zhang, L., Hill, W. G. & Yu, W. Evaluating the voiding spot assay in mice: a simple method with complex environmental interactions. Am. J. Physiol. Ren. Physiol. 313, F1274\u2013F1280 (2017).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"18167_CR63","doi-asserted-by":"crossref","first-page":"5288","DOI":"10.1096\/fj.14-255885","volume":"28","author":"W Yu","year":"2014","unstructured":"Yu, W., Sun, X., Robson, S. C. & Hill, W. G. ADP-induced bladder contractility is mediated by P2Y12 receptor and temporally regulated by ectonucleotidases and adenosine signaling. FASEB J. 28, 5288\u20135298 (2014).","journal-title":"FASEB J."},{"key":"18167_CR64","doi-asserted-by":"crossref","unstructured":"Hao, Y. et al. Targetable purinergic receptors P2Y12 and A2b antagonistically regulate bladder function. JCI Insight 4, 16 (2019).","DOI":"10.1172\/jci.insight.122112"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-18167-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-18167-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-18167-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T15:09:38Z","timestamp":1723475378000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-18167-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,28]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["18167"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-18167-4","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.738575277.793579428","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,28]]},"assertion":[{"value":"28 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4328"}}